|1.||Minatoguchi, Shinya: 3 articles (07/2009 - 06/2003)|
|2.||Fujiwara, Hisayoshi: 3 articles (07/2009 - 06/2003)|
|3.||Takemura, Genzou: 3 articles (07/2009 - 06/2003)|
|4.||Piersma, Sander R: 2 articles (01/2010 - 02/2006)|
|5.||Altelaar, A F Maarten: 2 articles (01/2010 - 02/2006)|
|6.||Conejero, Vicente: 2 articles (01/2010 - 02/2006)|
|7.||Fujiwara, Takako: 2 articles (07/2009 - 12/2007)|
|8.||Kobayashi, Hiroyuki: 2 articles (07/2009 - 12/2007)|
|9.||Yasuda, Shinji: 2 articles (07/2009 - 12/2007)|
|10.||Misao, Yu: 2 articles (12/2007 - 06/2003)|
11/28/2004 - "The present study was carried out to study the effect of gentisic acid (2,5-dihydroxybenzoic acid (2,5-DHBA)) on the tumor promotion related events of carcinogenesis in murine skin. "
10/09/2011 - "2,5-dihydroxybenzoic acid / α-cyano-4-hydroxycinnamic acid were manually deposited on tumor-rich areas, and mass spectra were acquired using a MALDI-time of flight instrument. "
01/01/2014 - "In this study, we performed lipid imaging and profiling for 134 tissue samples from six different types of cancer using matrix-assisted laser desorption/ionization-Fourier transform ion cyclotron resonance mass spectrometry, with 2,5-dihydroxybenzoic acid and 1,8-bis(dimethyl-amino)naphthalene as matrices in the positive and negative ion modes, respectively. "
11/28/2004 - "Modulatory effect of gentisic acid on the augmentation of biochemical events of tumor promotion stage by benzoyl peroxide and ultraviolet radiation in Swiss albino mice."
03/22/2007 - "Our results suggest that the new 2,5-dihydroxybenzoate molybdenum(VI) complex may provide a valuable tool in cancer chemotherapy."
01/01/1993 - "20 min before ischemia was shown to dose dependently suppress the rise of 2,5-dihydroxybenzoic acid after reperfusion. "
01/01/1993 - "The results indicate that the concentration of 2,5-dihydroxybenzoic acid in the perfusates was highest during 25 min reperfusion and no change was found during ischemia. "
03/01/1991 - "2,5-dihydroxybenzoic acid was present only after aerobic reperfusion and was not detected before ischemia. "
01/01/1990 - "The duration of ischemia did not significantly affect tissue content of 2,5-dihydroxybenzoic acid peaked at 250 to 300% of control within 2.5 min of reperfusion. "
01/01/1990 - "Following 20 min of global ischemia a 173% increase in tissue content of 2,5-dihydroxybenzoic acid was detected after 2.5 min of reperfusion. "
06/01/2007 - "Na(+),K(+) ATPase and total ATPase activity was significantly increased in group V. Levels of GSH showed a significant increase in group III, besides, levels of 2,5-dihydroxybenzoic acid as salicylate in plasma were significantly increased in group II. These results elucidate differences in the biochemical response of animal towards intake of various types of antioxidant substances, with increased GSH and salicylate in hyperoxia."
06/01/2007 - "Assessment of antioxidant effect of 2,5-dihydroxybenzoic acid and vitamin a in brains of rats with induced hyperoxia."
06/01/2007 - "The aim of this study was to evaluate the effect of 2,5-dihydroxybenzoic acid, a salicylate derived from Acetyl salicylic acid (ASA) and vitamin A (vit A) on Na(+), K(+) ATPase enzyme and GSH levels in brain of rats exposed to hyperoxia (Hyp) as oxidant protocol. "
|4.||Rheumatic Diseases (Rheumatism)
|5.||Body Weight (Weight, Body)
08/01/2006 - "According to the results, gentisic acid, gallic acid and p-coumaric acid in a dosage of 100 mg/kg of body weight for 14 consecutive days significantly increased P-form PST (PST-P) activity as compared with that of the control rats (P<.05), whereas the activity of M-form PST (PST-M) in rats that received gallic acid and p-coumaric acid were also significantly (P<.05) higher than in the control rats. "
02/01/2004 - "rosa sinensis extract (3.5 mg and 7 mg/kg body weight) and gentisic acid (2.0 microg and 4.0 microg/0.2 ml acetone per animal) restored the levels of GSH, and its metabolizing and antioxidant enzymes (P<0.05). "
01/01/2006 - "Rats were orally administrated gentisic acid (GEA), gallic acid (GA), ferulic acid (FA), and p-coumaric acid (p-CA) at a dosage of 100 mg/kg body weight for 14 consecutive days. "
|2.||Salicylic Acid (2 Hydroxybenzoic Acid)
|3.||Glutamic Acid (Glutamate)
|6.||Vitamin A (Retinol)
|8.||Adenosine Triphosphatases (ATPase)
|3.||Drug Therapy (Chemotherapy)